The clinical success of cancer gene therapy critically depends on the development of safe, efficient, and targeted gene carriers. [2] In recent years, synthetic nonviral vectors have attracted great attention as a promising alternative to conventional viral vectors owing to their lower risk of immunogenicity and larger gene delivery capacity.
[3] However, nonviral vectors often suffer from low transfection efficiency owing to their poor extra-and intracellular processes as compared to viral vectors. [4] In addition, the lack of target-specificity for nonviral vectors is another critical obstacle that needs to be overcome before their maximized therapeutic efficacy can be achieved at the target site. [4] Recently, various types of smart polymers capable of responding to the stimuli intrinsic to a tumor environment have emerged as efficient nonviral gene carriers for the treatment of cancer. [5] Most of the stimuli-responsive nonviral vectors rely on the use of extracellular environments of tumors, such as low extracellular tumor pH value and matrix metalloproteinases (MMPs), for cancer-targeted gene delivery.
[6] Few of them have been developed with responses to the unique intracellular stimuli of cancer cells, which could be used to greatly improve their intracellular trafficking and gene transfection.
Recent studies reported that, owing to oncogenic transformation, cancer cells constantly generate high levels of intracellular reactive oxygen species (ROS), including H 2 O 2 , hydroxyl radical, and superoxide, in comparison with normal cells. [7] Therefore, in this study, the intracellular ROS in cancer cells was utilized as a unique cancer-related stimulus to mediate intracellular gene delivery. We demonstrated efficient and safe gene delivery in cancer cells by developing a novel ROS-responsive, cationic, water-soluble polymer composed of biodegradable thioketal linkages that are readily cleavable in ROS-abundant conditions.
[8] It was hypothesized that the ROS-cleavable thioketal-based polymeric carrier could enhance the gene delivery efficiency in cancer cells by facilitating intracellular release of the encapsulated nucleic acids in response to high levels of intracellular ROS (Figure 1 a) . We further functionalized this polymer with a cancertargeting peptide to achieve cancer-targeted gene delivery. This modification could enhance the gene delivery efficiency and thus reduce the potential systemic toxicity by avoiding nonspecific accumulation in normal cells.
The ROS-cleavable, cationic polymer was synthesized by polymerization of oligoamines with acrylamide thioketal cross-linkers (Figure 1 b) . Briefly, trifluoroacetate (TFA)- Figure 1 . a) Illustration of intracellular delivery of plasmid DNA to the nucleus of a cancer cell using ROS-cleavable poly(amino thioketal) (PATK). After the DNA/PATK polyplexes have been internalized by the cancer cell and escaped from the endosome, ROS-triggered degradation of the PATK facilitates the intracellular release of DNA from the particle, leading to enhanced gene transfection. b) Synthetic scheme of ROS-responsive PATK.
protected N,N'-bis(2-aminoethyl)-1,3-propanediamine was polymerized with the thioketal cross-linkers by Michael addition conjugation, followed by deprotection of the TFA groups, resulting in poly(amino thioketal) (PATK). Figure S1 a in the Supporting Information shows the detailed synthesis. Non-degradable poly(amine) without thioketal linkages was also synthesized as a ROS-insensitive counterpart to investigate the effects of ROS sensitivity on the intracellular release of nucleic acids and consequent gene delivery efficiency (see Figure S1 b for detailed synthesis). The formation of PATK was confirmed by the 1 H NMR spectroscopy ( Figure S2 a) . The molecular weights of PATK were M n = 5.7 kDa and M w = 9.4 kDa with a polydispersity index of 1.65, as determined by gel permeation chromatography (GPC).
The degradation profile of PATK under simulated ROS conditions was quantified by 1 H NMR spectroscopy. In a typical experiment, PATK was dissolved in D 2 O containing H 2 O 2 and trace amounts of transition-metal ions (e.g., 1.6 mm CuCl 2 ) to trigger its degradation by ROS. 3-(trimethylsilyl)-propionic acid sodium salt (TSP) was also added into the D 2 O solvent as a stable reference. When the PATK was incubated in the solvent at 37 8C for different times, the disappearance of the thioketal linkage peak (d = 1.62 ppm) was monitored and quantified using 1 H NMR spectroscopy in comparison with the TSP peak. The 1 H NMR spectrum confirmed that the thioketal linkages were efficiently cleaved by ROS, generating acetone (d = 2.16 ppm) as a by-product during the cleavage process (data not shown). This finding was in agreement with a previous study regarding the dethioacetalization using H 2 O 2 . [9] The degradation rate of thioketal linkages was proportional to the concentration of H 2 O 2 as shown in Figure 2 a. For example, the half-lives of thioketal linkages in PATK incubated with 100 mm and 200 mm H 2 O 2 solution were approximately 20 h and 11 h, respectively (Figure 2 a) . The decrease in molecular weight of PATK after incubation with 100 mm H 2 O 2 and 1.6 mm CuCl 2 at 37 8C was also confirmed by GPC (Figure S2 b) .
Efficient DNA complexation by cationic PATK was confirmed by measuring the particle size and surface charge of DNA/PATK polyplexes. As shown in Figure S3 a, PATK efficiently complexed with DNA, forming stable polyplexes with diameters ranging from 130 to 200 nm at amine to phosphate (N/P) ratios of 50 and higher. The zeta potentials of DNA/PATK polyplexes were in the range of + 15 to + 25 mV at N/P ratios of 50 and higher ( Figure S3 b) . Efficient ROS-triggered dissociation of DNA from DNA/PATK polyplexes was confirmed by an agarose gel electrophoresis assay. Before incubation with a H 2 O 2 solution, DNA was completely retained by PATK at N/P ratios of 20 and higher ( Figure S4 ). However, DNA was efficiently liberated from the PATK polyplexes when the samples were exposed to ROS (Figure S4) . TEM images also demonstrated ROS-triggered destabilization of the DNA/PATK polyplexes (Figure 2 b) . In addition, destabilization of the DNA/PATK polyplexes in response to biologically relevant levels of H 2 O 2 (e.g., 100 mm and 1 mm) [10] was confirmed by ethidium bromide (EtBr) exclusion assay (Figure S5 a) . The degradation selectivity of the DNA/PATK polyplexes under various ROS, including hydroxyl radical, H 2 O 2 , and superoxide, was also examined using the EtBr exclusion assay (Figure S5 b) . Among the tested ROS, thioketal linkages showed the most efficient degradation in response to the hydroxyl radical.
To confirm whether cancer cells spontaneously generate ROS, we visualized intracellular ROS generation using 2',7-dichlorofluoresceindiacetate (DCFDA), a cell permeable fluorescent dye that is rapidly oxidized to a fluorescent molecule by intracellular ROS. [11] The PC3 cell, a human prostate cancer cell line, was used as a model system due to its inherently high levels of ROS.
[7a] Fluorescent micrographs of Figure S6 ).
Enhanced gene transfection by ROS-responsive PATK was investigated by comparing its transfection efficiency with reference to non-degradable poly(amine). As shown in Figure 3 a, eGFP expression (transfection) of the PC3 cells incubated with PATK polyplexes complexing eGFP-encoding plasmid DNA was significantly higher than that of the cells incubated with the DNA/non-degradable poly(amine) polyplexes. The transfection efficiency of PATK was also compared with B-PEI, a commercially available superior transfecting agent. Clearly, DNA/PATK polyplexes transfected PC3 cells more efficiently than DNA/B-PEI polyplexes (Figure 3 a) . It is established that intracellular release of DNA from the gene carrier is crucial for efficient gene transfection. [12] The confocal micrographs in Figure 2 d clearly shows that DNA was efficiently released from PATK polyplexes in PC3 cells. Taken together, enhanced gene transfection by the DNA/PATK polyplexes in comparison with DNA/non-degradable poly(amine) and DNA/B-PEI polyplexes can be attributed to their efficient intracellular disassembly in ROS-generating PC3 cells. In addition to higher gene transfection, ROS-sensitive DNA/PATK polyplexes exhibited lower cytotoxicity than DNA/B-PEI polyplexes (Figure 3 b) . In general, the cytotoxicity of cationic polymers increases with their charge density and molecular weights. [13] Therefore, the reduced cytotoxicity of PATK can be attributed to its lower molecular weight and lower cationic surface charge (DNA/PATK: ca. 20 mV, DNA/B-PEI: ca. 30 mV; Figure S3 b) .
To investigate if the enhanced gene transfection by PATK is selectively triggered in response to high levels of ROS in cancer cells, its transfection efficiency in PC3 cells was compared with the Chinese hamster ovary (CHO) cells that produce significantly lower levels of ROS ( Figure S7a ). PATK showed significantly higher transfection efficiency in PC3 cells than in non-cancerous CHO cells (Figure 3 a and Figure S7 b) , whereas non-degradable B-PEI showed similar transfection efficiencies for both PC3 and CHO cells. Considering that the total cellular uptake of both DNA/PATK and DNA/B-PEI polyplexes was similar for both PC3 and CHO cells ( Figure S7 c) , the noticeably enhanced gene transfection by PATK in PC3 cells can be attributed to more efficient disassembly of the DNA/PATK polyplexes in PC3 cells that are known to have higher levels of ROS. The significantly enhanced gene transfection by PATK in response to high levels of ROS in prostate cancer cells was also consistently observed in LNCaP cells, another prostate cancer cell line showing higher levels of intracellular ROS than those of noncancerous CHO cells ( Figure S7 ).
Cancer-targeted gene delivery is a key requirement for future cancer gene therapy in the clinic. [14] To demonstrate the feasibility of achieving cancer-targeted gene delivery using the ROS-responsive PATK, we further conjugated it with GRP78-binding peptide (GRP78P, peptide sequence = WIFPWIQL) ( Figure S8 ), which selectively binds to GRP78 proteins over-expressed by many types of tumor cells including the prostate cancer cells. [15] We then complexed fluorescently labeled DNA with the GRP78P-conjugated PATK (GRP78P-PATK) or GRP78P-free PATK to quantify their cellular uptake. Notably, the conjugation of GRP78P significantly increased (ca. three-fold higher) cellular uptake of the PATK polyplexes in PC3 cells (Figure 4) . Consequently, DNA/GRP78P-PATK polyplexes yielded a two-fold higher gene transfection efficiency in PC3 cells in comparison with DNA/GRP78P-free PATK polyplexes. To confirm that the increased transfection efficiency by DNA/GRP78P-PATK polyplexes was mainly caused by the receptor-mediated cellular uptake of GRP78P, a competitive assay where free GRP78P was pre-incubated with PC3 cells prior to the transfection was conducted. When 200 mm of free GRP78P was pre-incubated with the cells prior to the transfection, the DNA/GRP78P-PATK polyplexes showed significantly Figure 3 . a) Transfection efficiency and b) cell viability for DNA/PATK (N/P = 100), DNA/non-degradable poly(amine) (N/P = 120), and DNA/B-PEI polyplexes (N/P = 9) in PC3 cells. The N/P ratios of the polyplexes were determined by optimized transfection efficiency and cytotoxicity. * indicates p < 0.05. ** indicates p < 0.01. decreased DNA transfection (Figure 4 ). Combined together, these results confirm that DNA/GRP78P-PATK polyplexes are efficiently internalized by the cancer cells by GRP78 receptor-mediated endocytosis, leading to caner-targeted gene delivery.
In conclusion, ROS-responsive thioketal-based PATK was synthesized for safe, efficient, and targeted gene delivery in prostate cancer cells. Degradation of thioketal linkages in PATK under ROS conditions led to efficient intracellular release of the complexed DNA in prostate cancer cells. As a result, the DNA/PATK polyplexes exhibited efficient gene transfection in prostate cancer cells. Incorporation of GRP78-binding peptide to the PATK achieved cancer-targeted gene transfection. Most importantly, this study demonstrates that the high levels of intracellular ROS in cancer cells are unique biological stimuli that can be utilized for efficient and targeted gene delivery in cancer cells.
